Art

J-GLOBAL ID：200902271687081264   Reference number：09A0131465

In vivo anti-tumor effect of PEG liposomal doxorubicin (DOX) in DOX-resistant tumor-bearing mice: Involvement of cytotoxic effect on vascular endothelial cells

ドキソルビシン(DOX)抵抗性腫瘍もつマウスにおけるPEGリポソーマルDOXのin vivo抗腫瘍作用:血管内皮細胞に対する細胞毒性作用の関与

Author (5)： OGAWARA Ken-ichi (Okayama Univ., Okayama, JPN) ,  UN Keita (Okayama Univ., Okayama, JPN) ,  TANAKA Ken-ichi (Shujitsu Univ., Okayama, JPN) ,  HIGAKI Kazutaka (Okayama Univ., Okayama, JPN) ,  KIMURA Toshikiro (Okayama Univ., Okayama, JPN)
Material： Journal of Controlled Release  (J Control Release)
Volume： 133  Issue： 1  Page： 4-10  Publication year： Jan. 05, 2009 
JST Material Number： C0308D  ISSN： 0168-3659  Document type： Article
Article type： 原著論文  Country of issue： Netherlands (NLD)  Language： ENGLISH (EN)

Thesaurus term： tumor cell ,...
Semi thesaurus term： C26/DOX ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=09A0131465&from=J-GLOBAL&jstjournalNo=C0308D") }}

JST classification (3)： Basic oncology in general  (GE02010R) ,  Basic research of antitumor(=antineoplastic)antibiotics  (GX05040Y) ,  Pharmaceutical preparations in general  (GY02010Z)

Substance index (1)： Doxorubicin

Reference (48)：

• H.C. Chung, S.Y. Rha, J.H. Kim, J.K. Roh, J.S. Min, K.S. Lee, B.S. Kim, K.B. Lee, P-glycoprotein: the intermediate end point of drug response to induction chemotherapy in locally advanced breast cancer, Breast Cancer Res. Treat. 42 (1997) 65-72.
• J. Lutzky, M.B. Astor, R.N. Taub, M.A. Baker, K. Bhalla, J.E. Gervasoni, M. Rosado, V. Stewart, S. Krishna, A.A. Hindenburg, Role of glutathione and dependent enzymes in anthracycline-resistant HL60/AR cells, Cancer Res. 49 (1989) 4120-4125.
• R.B. Montgomery, J. Guzman, D.M. O'Rourke, W.L. Stahl, Expression of oncogenic epidermal growth factor receptor family kinases induces paclitaxel resistance and alters beta-tubulin isotype expression, J. Biol. Chem. 275 (2000) 17358-17363.
• Y. Miyoshi, A. Ando, Y. Takamura, T. Taguchi, Y. Tamaki, S. Noguchi, Prediction of response to docetaxel by CYP3A4 mRNA expression in breast cancer tissues, Int. J. Cancer 97 (2002) 129-132.
• J. Tsurutani, T. Nitta, T. Hirashima, T. Komiya, H. Uejima, H. Tada, S. Negoro, A. Tohda, M. Fukuoka, K. Nakagawa, Point mutations in the topoisomerase I gene in patients with non-small cell lung cancer treated with irinotecan, Lung Cancer 35 (2002) 299-304.

Terms in the title (9)： ドキソルビシン ,  Dox ,  抵抗性 ,  腫瘍 ,  マウス ,  PEG ,  抗腫瘍作用 ,  血管内皮細胞 ,  細胞毒性作用